Studies confirm its regulatory influence over hepatocellular carcinoma progression through SIRT1 modulation [24] and its intimate link with hepatoblastoma via angiogenic control mediated by the JAK2/STAT3 pathway [25]. Here, JAK2 is linked to hepatocellular carcinoma.